Johnson & Johnson (JNJ) experienced a significant increase in total revenue for Q4 2024, reaching $22.52 billion1. This represents a substantial growth in earnings compared to the previous quarter. However, the specific expenses for the period are not available. The reported end date for the financial data is December 29, 2024.